By addressing the challenges through scale up and along the supply chain this event will enable more cost effective and lower risk production of highly potent drugs. As the potency and number of drugs increases there is a lot for the industry to still learn. This year’s program has been specifically designed to provide cutting edge case studies and real world applicable approaches to: Overcome tech transfer challenges by understanding how to develop robust and scalable processes which will maintain quality & yield of HPAPI production once outsourcedImprove employee protection at early drug development stages by hearing best practice for safe handling and exposure controlStreamline HPAPI development and reduce cost by evaluating the latest single use technologiesKeep your HPAPI development tightly on track by breaking down existing organisational silos and optimize cross-functional collaborationIdentify cutting edge containment solutions and learn how they can improve your potent handling capabilitiesEvaluate new technologies which will provide you with increased protection from cross-contamination in multi-product facilitiesHear insights into making your CMO selection to propel the smooth production of your HPAPI compound